Final Bids In: Inside Estée Lauder’s Latest Divestiture Move
Estée Lauder has entered the final stretch of a high‑stakes portfolio shake‑up, having received final bids for Too Faced, Smashbox and Dr. Jart+. Initially marketed as a single bundle, the assets were later split, with Too Faced and Smashbox offered together and Dr. Jart+ marketed separately. At least one suitor has reportedly considered buying all three, while others are targeting only the makeup duo or focusing purely on Dr. Jart acquisition prospects. Estée Lauder has declined to comment, but the timing aligns with CEO Stéphane de La Faverie’s earlier pledge to review the company’s portfolio to sharpen performance and streamline operations. The sales process, expected to conclude within weeks, unfolds against a backdrop of exploratory talks with Puig over a potential business combination, underscoring how aggressively Estée Lauder is re‑architecting its position in a consolidating beauty brand acquisition landscape.
Strategic Priorities: Why These Brands Are on the Block
The planned Estée Lauder divestiture reflects a broader strategic reset rather than a simple cash‑raising exercise. Too Faced and Smashbox occupy overlapping color cosmetics territory, from playful, trend‑driven palettes to professional‑leaning artistry tools—the very segments most exposed to fast‑moving indie competition and social‑media cycles. Dr. Jart+, by contrast, sits squarely in treatment‑driven skincare with a clinical‑meets‑fun K‑beauty DNA. Offloading all three allows Estée Lauder to simplify its lineup, reduce internal brand cannibalisation and redirect resources toward higher‑growth, core franchises that better fit its long‑term priorities. It may also create operational flexibility ahead of any deeper tie‑up with Puig, where a cleaner, more focused portfolio can be easier to integrate. In essence, the Too Faced sale, Smashbox ownership changes and potential Dr. Jart acquisition collectively signal a pivot from breadth toward strategic depth.
Too Faced and Smashbox: Color Icons at a Crossroads
Too Faced and Smashbox, once emblematic of the prestige makeup boom, now face a pivotal transition as Estée Lauder reshapes its portfolio. Too Faced helped define playful, influencer‑friendly color cosmetics, while Smashbox earned credibility in photography‑ready, artistry‑driven makeup. Bundling them in the sale process suggests buyers see synergy in controlling both a whimsical consumer brand and a more professional‑leaning label. For potential acquirers, the prize is access to established distribution, strong brand awareness and communities that can be re‑energised with sharper positioning and faster innovation cycles. For Estée Lauder, exiting these segments trims exposure to crowded indie makeup battlegrounds and frees capital and management attention for skincare and hero franchises. The outcome will redefine who steers two of the most recognisable names in prestige makeup—and how they compete in an increasingly fragmented color cosmetics market.
Dr. Jart+: A Potential Return to Its Roots
Dr. Jart+ is on a different trajectory from its makeup peers, with Korean private equity firm PTA Partners reportedly pursuing a joint acquisition of its parent, Have & Be, from Estée Lauder. The move could return the brand to Korean ownership and closer to the K‑beauty ecosystem that originally propelled its rise. Since Estée Lauder’s full acquisition in 2019, Dr. Jart+ has struggled, with revenue dropping sharply and the brand slipping into operating losses. Industry observers argue that Estée Lauder failed to keep pace with evolving beauty trends and allowed domestic marketing muscle to weaken. PTA intends to leverage advanced local ODM and OEM capabilities, global influencer marketing and growing international appetite for K‑beauty to reignite growth. If successful, the deal would be a case study in how local operators can reclaim and revitalise brands that underperform inside global conglomerates.
What This Signals for the Future of Global Beauty Portfolios
The proposed exits of Too Faced, Smashbox and Dr. Jart+ crystallise how large beauty groups are re‑engineering portfolios for a new era. Estée Lauder is signalling that it will prioritise brands and categories where it believes it can sustain clear competitive advantage, while offloading assets that demand faster, more entrepreneurial execution. For buyers, this beauty brand acquisition wave offers ready‑made platforms in playful color cosmetics, indie‑style makeup and K‑beauty‑driven skincare. For the wider industry, the moves highlight a shift toward leaner, more focused brand rosters—especially as giants explore transformative deals such as Estée Lauder’s exploratory discussions with Puig. As final bids are evaluated, the reshuffling of Too Faced sale prospects, Smashbox ownership and a potential Dr. Jart acquisition will reshape not only individual labels, but also how global beauty powerhouses balance innovation, risk and scale.